Atlas Trials

Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia

Clinical trial NCT06174116 · RECRUITING

Trial details

NCT number
NCT06174116
Sponsor
University of Massachusetts, Worcester
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaSchizo Affective Disorder
Start date
2024-04-02
Primary completion
2026-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.